Active, Not Recruiting
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
NCT03912064
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States